Innoviva, Inc. (INVA) stock

INVANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 14/3040% below fair value

$19.03+0.06 (+0.32%)

Close on Nov 13, 2026Market cap $1.37BP/E 9.7Yield –

Innoviva profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Innoviva has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is INVA.

Revenue growth12.8% · median 240.0%

Operating margin38.8% · median -37.1%

Advertisement
300 × 250

See a number that looks wrong?